They commented that these findings suggest that REV-7 could act as a suppressor of colorectal cancer progression and metastasis. Furthermore, high REV-7 expression was a predictive factor of favorable prognosis, while high NCOA3 expression was associated with poor prognosis. Here, MAD2L2 is linked to colorectal cancer.